Please login to the form below

Not currently logged in
Email:
Password:

Apeiron bolsters management board

Peter Llewellyn-Davies joins as its CFO and CBO

Van De WinkelViennese cancer-immunotherapy focused group Apeiron Biologics has appointed a new chief financial officer and chief business officer in the form of Peter Llewellyn-Davies.

With more than 25 years’ experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently ran his own consulting firm Accellerate Partners.

He said: “Apeiron is currently amongst the most compelling privately owned European biotech companies and I am looking forward to working together with the team to jointly lead Apeiron through the next phase of growth.”

During the course of his career, Llewellyn-Davies supported Medigene’s strategy to form an immunotherapy company and he assisted in initial public offerings for Wilex.

Dr Hans Loibner, chief executive officer, Apeiron, said: “Peter’s expertise, which has been proven by many international capital market transactions, is highly welcome, and he is an ideal addition to support our growth strategy.

“I very much look forward to working hand in hand with him.”

7th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics